Krishna Institute of Medical Sciences (NSE:KIMS) EBIT: ₹5,364 Mil (TTM As of Mar. 2026)


NSE:KIMS Krishna Institute of Medical Sciences Ltd NSE:KIMS
87 GF Score
Price ₹795.35
GF Value ₹776.44
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Krishna Institute of Medical Sciences EBIT?

Krishna Institute of Medical Sciences NSE:KIMS -0.23% 87 EBIT is ₹5,364 Mil as of Mar. 2026. GuruFocus rates NSE:KIMS with a GF Score™ of 87/100 and a GF Value™ of ₹776.44 (Fairly Valued). The stock has 7 warning signs investors should review.

Krishna Institute of Medical Sciences's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was ₹1,229 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹5,364 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Krishna Institute of Medical Sciences's annualized ROC % for the quarter that ended in Mar. 2026 was 3.79%. Krishna Institute of Medical Sciences's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 8.19%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Krishna Institute of Medical Sciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 1.48%.


Krishna Institute of Medical Sciences  (NSE:KIMS) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Krishna Institute of Medical Sciences's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=4860 * ( 1 - 39.6% )/( (0 + 77374)/ 1 )
=2935.44/77374
=3.79 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Krishna Institute of Medical Sciences's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=4916/( ( (0 + max(0, 0)) + (59207 + max(845, 0)) )/ 1 )
=4916/( ( 0 + 60052 )/ 1 )
=4916/60052
=8.19 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(5542 + 969 + 568) - (3228 + 0 + 3006)
=845

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Krishna Institute of Medical Sciences's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=5364/362377.523
=1.48 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Krishna Institute of Medical Sciences EBIT Related Terms


Krishna Institute of Medical Sciences EBIT Historical Data

* Premium members only.

The historical data trend for Krishna Institute of Medical Sciences's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krishna Institute of Medical Sciences EBIT Chart

Krishna Institute of Medical Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial 4,728.86 5,142.25 5,059.00 6,484.00 5,364.00

Krishna Institute of Medical Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,607.00 1,463.00 1,418.00 1,254.00 1,229.00

NSE:KIMS vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, Krishna Institute of Medical Sciences's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Krishna Institute of Medical Sciences EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Krishna Institute of Medical Sciences's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Krishna Institute of Medical Sciences's EV-to-EBIT falls into.


NSE:KIMS
87GF Score
Krishna Institute of Medical Sciences Ltd NSE:KIMS
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Krishna Institute of Medical Sciences EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹5,364 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹5,364 Mil mean?
Krishna Institute of Medical Sciences (NSE:KIMS) has a EBIT of ₹5,364 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Krishna Institute of Medical Sciences.
Is Krishna Institute of Medical Sciences' EBIT too high?
Krishna Institute of Medical Sciences' current EBIT is ₹5,364 Mil. Overall, Krishna Institute of Medical Sciences has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Krishna Institute of Medical Sciences' EBIT compare to HCA and THC?
Krishna Institute of Medical Sciences' EBIT of ₹5,364 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Krishna Institute of Medical Sciences. Krishna Institute of Medical Sciences's current EBIT is ₹5,364 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krishna Institute of Medical Sciences stock overvalued right now?
Based on GuruFocus' analysis, Krishna Institute of Medical Sciences (NSE:KIMS) is currently considered Fairly Valued. The stock's GF Value™ is ₹776.44, compared to a current price of ₹795.35 — trading 2.4% above its estimated fair value. The current EBIT is ₹5,364 Mil. Krishna Institute of Medical Sciences' overall GF Score™ is 87/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Krishna Institute of Medical Sciences (NSE:KIMS), the current EBIT is ₹5,364 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Krishna Institute of Medical Sciences (NSE:KIMS) Overvalued in 2026?

Based on GuruFocus' analysis, Krishna Institute of Medical Sciences stock appears to be overvalued. The current stock price of ₹795.35 is trading 2.4% above its estimated GF Value™ of ₹776.44. GuruFocus considers Krishna Institute of Medical Sciences to be Fairly Valued.

Key valuation signals for NSE:KIMS:

  • EBIT: ₹5,364 Mil
  • GF Value™: ₹776.44 vs. price of ₹795.35 (2.4% above fair value)
  • GF Score™: 87/100 with 7 warning signs

No single metric tells the full story. See the NSE:KIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Krishna Institute of Medical Sciences Business Description

Other Exchanges 543308:India
Address D. No. 1-8-31/1, Minister Road, Secunderabad, TG, IND, 500 003
Krishna Institute of Medical Sciences Ltd is a healthcare group in Secunderabad and Telangana. It offers a comprehensive range of healthcare services, including oncology, cardiac sciences, neurosciences, gastric sciences, orthopedics, renal sciences, organ transplantation, mother and child care, and many more. The firm generates key revenue from Hospital services and Pharmacy.
87GF Score

Get the complete analysis for NSE:KIMS

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹795.35
Price
₹776.44
GF Value